Skip to main content

Table 3 Patient summary statistics

From: Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial

 

Intervention

Control

pvalue

All Patients* (n)

5560

5820

 

Consenting Patients** (n)

2858

2788

Mean HbA1c at baseline (SD)**

7.11 (0.43)

7.19 (0.52)

0.32

Mean years since T2DM diagnosis (SD)**

7.9 (2.54)

8.0 (2.90)

0.80

Mean number of insulin-eligible patients at time of workshop per physician (n,%)

10.9 (5.80)

11.3 (7.09)

0.70

Mean HbA1c of insulin-eligible patients at time of workshop (SD)**

8.6 (0.59)

8.6 (0.76)

0.74

Mean number of patients newly prescribed insulin between Workshop and 12 months post (SD)**

1.8 (1.87)

1.9 (1.71)

0.91

Mean number of office visits during study for insulin-eligible patients at the time of insulin initiation (SD)

6.0 (2.24)

5.9 (2.39)

0.84

Mean elapsed time in days, workshop to first office visit for insulin-eligible patients at the time of insulin initiation (SD)

45.3 (32.92)

65.4 (53.99)

0.04

  1. *All patients with T2DM in practice.
  2. **Data from consenting patients’ charts only.